美 英 un.急性淋巴细胞性白血病 英汉 英英 un. 1. 急性淋巴细胞性白血病
What is acute lymphocytic leukemia (ALL)?ALL is cancer that affects the blood and bone marrow. The bone marrow makes white blood cells (WBC), red blood cells (RBC), and platelets. WBCs help fight infection. RBCs help carry oxygen throughout the body. Platelets help the blood clot. ALL ...
M 4 ( 急性粒 - 单核细胞白血病 ,acute myeiomonocytic leukemia,AMML) 骨髓中原始细胞占 NEC 的 30% 以上,各阶段粒细胞占 30%~80%, 各阶段单核细胞 >20% .①M4a:原始和早幼粒细胞增生为主,原幼单和单核细胞>20%(非红系细胞);②M4b:原、幼单核细胞增生为主,原始和早幼粒细胞>20%(非红系细胞)...
Acute Lymphocytic Leukemia (ALL)Childhood Leukemiadoi:10.1007/978-0-387-79061-9_4497Tasha R. HoweJeffrey S. TrotterAndrew S. DavisJanet Ward SchofieldTracey McLellan
Acute myeloid leukemia (AML) also called acute myelocytic leukemia, acute myelogenous leukemia, acute granulocytic leukemia, or acute non-lymphocytic leukemia is a kind of leukemia that starts in the myeloid cells. These cells are capable of self-renewing and sustaining malignant populations as well ...
With the availability of rDNA-GH, GH is applied in experimental trials to other groups of patients than with GH-deficiency. Most effects of GH and GH-factors are clear; an effect of malignant degeneration is unknown.doi:10.1203/00006450-198810000-00124Delemarre-van de Wall, Henriette A...
Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century. J Hematol OncolJ Hematol Oncol 22 mars. 2016;9:28. Article Google Scholar Pulte D, Weberpals J, Jansen L, Luttmann S, Holleczek B, Nennecke A, et al....
The objective of this study was to determine the effect of place and type of initial treatment on survival from acute lymphocytic leukemia (ALL). Every one of the 327 children under 15 years of age diagnosed with ALL from 1970 to 1975 in a 31-county area designated the Greater Delaware Val...
North America dominated the Acute Lymphocytic/Lymphoblastic Leukemia Market with a major share of 40% in 2020. This is owing to soaring advancements in technology that improve the treatment for acute lymphocytic leukemia. Moreover, the large number of companies are developing a variety of drugs for...
We investigated CD4+CD34+, CD8+CD34+, CD4+CD34−, and CD8+CD34− T cells from cord blood and from typical patients with T-cell-lineage acute lymphocytic leukemia and T-cell-lineage chronic lymphocytic leukemia in terms of expression and functions of CXCR5/CXCL13. We found that CXCR5 was...